Skip Navigation



NDT Advance Access published online on March 7, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl065
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/7/1778    most recent
gfl065v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hartner, A.
Right arrow Articles by Hilgers, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartner, A.
Right arrow Articles by Hilgers, K. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received May 31, 2005
Accepted February 3, 2006

Original Article

Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats

Andrea Hartner 1 *, Markus Porst 1, Bernd Klanke 2, Nada Cordasic 2, Roland Veelken 2, and Karl F. Hilgers 2

1 University Hospital for Children and Adolescents, Erlangen, Germany
2 Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen, Germany

* To whom correspondence should be addressed.
Andrea Hartner, E-mail: andrea.hartner{at}rzmail.uni-erlangen.de



  Abstract

Background. Ren-2 transgenic hypertensive rats develop malignant hypertensive nephrosclerosis despite low to normal plasma angiotensin II and suppressed renal renin. We tested the hypothesis that local angiotensin II formation occurs at sites of renal vascular and interstitial injury in this model.

Methods. Heterozygous Ren-2 transgenic rats were compared with normotensive Sprague-Dawley-Hannover control rats and Ren-2 transgenic rats treated with a very low dose of an angiotensin II type 1 (AT1) receptor antagonist, 1 mg/kg/day losartan, for 4 weeks. Blood pressure measurements, quantifications of urinary albumin, plasma and tissue angiotensin II as well as immunohistochemical analyses were performed.

Results. Systolic blood pressure was not affected by losartan during the study but intra-arterial recordings revealed a decrease of blood pressure. Losartan reduced albumin excretion, cell proliferation, macrophage influx, collagen I and collagen IV deposition. Plasma angiotensin II was decreased, while kidney tissue angiotensin II content was increased in Ren-2 transgenic rats compared with control rats. In Ren-2 transgenic rats, juxtaglomerular renin and angiotensin II staining were reduced, but there was a marked angiotensin II staining at foci of tubulo-interstitial fibrosis and at proliferative malignant vascular lesions.

Conclusion. We conclude that local angiotensin II formation is increased in proliferative or fibrotic kidney lesions in the Ren-2 transgenic rat. Local angiotensin II formation may help to explain why the AT1 receptor antagonist prevents or ameliorates this transgenic model of malignant nephrosclerosis despite low to normal plasma angiotensin II and suppressed renal renin.

Keywords: angiotensin II; AT1 receptor antagonist; hypertension; nephrosclerosis; Ren-2 transgenic rats.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. Chung, C. W. Park, S. J. Shin, J. H. Lim, H. W. Chung, D.-Y. Youn, H. W. Kim, B. S. Kim, J.-H. Lee, G.-H. Kim, et al.
Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats
Nephrol. Dial. Transplant., September 11, 2009; (2009) gfp472v1.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. H. Westhoff, K. F. Hilgers, M. P. Steinbach, A. Hartner, B. Klanke, K. Amann, and A. Melk
Hypertension Induces Somatic Cellular Senescence in Rats and Humans by Induction of Cell Cycle Inhibitor p16INK4a
Hypertension, July 1, 2008; 52(1): 123 - 129.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Hartner, N. Cordasic, B. Klanke, M. Wittmann, R. Veelken, and K. F. Hilgers
Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F820 - F827.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.